AU607461B2 - Sterilization of compositions of limited stability - Google Patents

Sterilization of compositions of limited stability Download PDF

Info

Publication number
AU607461B2
AU607461B2 AU11336/88A AU1133688A AU607461B2 AU 607461 B2 AU607461 B2 AU 607461B2 AU 11336/88 A AU11336/88 A AU 11336/88A AU 1133688 A AU1133688 A AU 1133688A AU 607461 B2 AU607461 B2 AU 607461B2
Authority
AU
Australia
Prior art keywords
formulation
range
buffer
concentration
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU11336/88A
Other languages
English (en)
Other versions
AU1133688A (en
Inventor
Stephen J. Foster
Milos Sovak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guerbet LLC
Original Assignee
Cook Imaging Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cook Imaging Corp filed Critical Cook Imaging Corp
Publication of AU1133688A publication Critical patent/AU1133688A/en
Application granted granted Critical
Publication of AU607461B2 publication Critical patent/AU607461B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/04—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/90—In vivo diagnostic or in vivo test agent which contains an additional ingredient to reduce the toxicity or side effects of the active ingredient

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU11336/88A 1987-02-05 1988-02-05 Sterilization of compositions of limited stability Expired AU607461B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/011,016 US4863714A (en) 1987-02-05 1987-02-05 Sterilization of compositions of limited stability
US011016 1987-02-05

Publications (2)

Publication Number Publication Date
AU1133688A AU1133688A (en) 1988-08-11
AU607461B2 true AU607461B2 (en) 1991-03-07

Family

ID=21748489

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11336/88A Expired AU607461B2 (en) 1987-02-05 1988-02-05 Sterilization of compositions of limited stability

Country Status (9)

Country Link
US (1) US4863714A (https=)
EP (1) EP0278674B1 (https=)
JP (1) JPH0667855B2 (https=)
AT (1) ATE79279T1 (https=)
AU (1) AU607461B2 (https=)
CA (1) CA1300005C (https=)
DE (1) DE3873553T2 (https=)
ES (1) ES2034184T3 (https=)
GR (1) GR3006111T3 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU638235B2 (en) * 1989-03-17 1993-06-24 Nycomed As Contrast media

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9020091D0 (en) * 1990-09-14 1990-10-24 Nycomed As Contrast media
DE4015832A1 (de) * 1990-05-17 1991-11-21 Thomae Gmbh Dr K Verfahren zur inaktivierung der biologischen aktivitaet von dna
AU701724B2 (en) * 1994-07-01 1999-02-04 Baxter International Inc. Biochemically balanced peritoneal dialysis solutions
US5605934A (en) * 1995-03-23 1997-02-25 Baxter International Inc. Method of manufacturing and storing solutions
US5972225A (en) * 1996-05-07 1999-10-26 Cook Imaging Corporation Process for remediating endotoxin-contaminated bulk non-ionic contrast media
US6309673B1 (en) 1999-09-10 2001-10-30 Baxter International Inc. Bicarbonate-based solution in two parts for peritoneal dialysis or substitution in continuous renal replacement therapy
US7122210B2 (en) 2002-01-11 2006-10-17 Baxter International Inc. Bicarbonate-based solutions for dialysis therapies
US7445801B2 (en) * 2002-06-07 2008-11-04 Baxter International Inc. Stable bicarbonate-based solution in a single container
US20060094700A1 (en) * 2004-11-02 2006-05-04 Allergan, Inc. Heat sterilization of a steroid in the presence of phosphate
US7935070B2 (en) * 2005-01-28 2011-05-03 Fresenius Medical Care North America Systems and methods for dextrose containing peritoneal dialysis (PD) solutions with neutral pH and reduced glucose degradation product
JPWO2008146731A1 (ja) * 2007-05-25 2010-08-19 味の素株式会社 末梢静脈投与用輸液の製造方法
KR101915821B1 (ko) * 2010-03-23 2018-11-06 지이 헬스케어 에이에스 안정화된 ｘ―선 진단용 조성물의 제조
US9585810B2 (en) 2010-10-14 2017-03-07 Fresenius Medical Care Holdings, Inc. Systems and methods for delivery of peritoneal dialysis (PD) solutions with integrated inter-chamber diffuser

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4720085A (en) * 1984-10-09 1986-04-17 Guerbet S.A. Iodo triaminobenzenes
AU2087088A (en) * 1987-07-24 1989-03-01 Nycomed As Iodinated esters

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4224440A (en) * 1975-05-15 1980-09-23 Mallinckrodt, Inc. 1-(3,5-Disubstituted-2,4,6-triiodophenly)-3-(polyhydroxy-alkyl)urea compounds
AT371998B (de) * 1978-07-04 1983-08-25 Nyegaard & Co As Verfahren zur herstellung einer sterilen injizierbaren physiologisch annehmbaren loesung eines roentgenkontrastmittels
GB2031405B (en) * 1978-07-04 1983-06-15 Nyegaard & Co As Process for the preparation of a sterile injectable physiologically acceptable solution of an x-ray contrast agent and solutions of the x-ray contrast agent and a buffer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4720085A (en) * 1984-10-09 1986-04-17 Guerbet S.A. Iodo triaminobenzenes
AU2087088A (en) * 1987-07-24 1989-03-01 Nycomed As Iodinated esters

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU638235B2 (en) * 1989-03-17 1993-06-24 Nycomed As Contrast media

Also Published As

Publication number Publication date
JPH0667855B2 (ja) 1994-08-31
AU1133688A (en) 1988-08-11
EP0278674A2 (en) 1988-08-17
DE3873553D1 (de) 1992-09-17
ES2034184T3 (es) 1993-04-01
US4863714A (en) 1989-09-05
DE3873553T2 (de) 1993-02-18
GR3006111T3 (https=) 1993-06-21
EP0278674A3 (en) 1989-07-19
ATE79279T1 (de) 1992-08-15
JPH01221330A (ja) 1989-09-04
EP0278674B1 (en) 1992-08-12
CA1300005C (en) 1992-05-05

Similar Documents

Publication Publication Date Title
AU607461B2 (en) Sterilization of compositions of limited stability
JP4861162B2 (ja) 注射用パラセタモール液状製剤
US6207201B1 (en) Sodium hypochlorite based disinfectant and sterilizer for medical-surgical instruments
PT772669E (pt) Solucao salina para o tratamento de lentes de contacto
Gallotti et al. The chemistry of iomeprol and physico-chemical properties of its aqueous solutions and pharmaceutical formulations
JP4543679B2 (ja) 唯一の共同溶剤としてプロピレングリコールを含んでいる使用準備ができているパラセタモール注射溶液
NO953638L (no) Gass-genererende kontrastmidler
EP0274714A1 (en) Topical preparation containing ofloxacin
CN114767548B (zh) 具有高流动性的无水根管消毒剂基质及应用其的消毒剂和应用
US10952963B2 (en) Ready to use liquid RECK formulation
US5650421A (en) Premixed famotidine formulation
JP3672342B2 (ja) ビスホスホン酸又はその誘導体を含有する注射液とその安定化方法、及び注射液アンプル
US2858320A (en) Stable hematoporphyrin
JP2596764B2 (ja) 腸管洗浄液剤
US2694487A (en) Flexibility of catgut sutures
CN112999388B (zh) 一种可吸收植入物及配套器械组合产品的灭菌方法
JPH06505028A (ja) 無緩衝のプレミックスされたラニチジン製剤
CA2342066A1 (en) Stabilized disinfectant preparation containing peroxides
ES2333863T3 (es) Formulaciones de medios de contraste para mejorar la tolerancia biologica.
Slagle et al. Unusual case of central vein thrombosis and sepsis
Montgomery et al. Evaluation of a new contrast medium for hysterosalpingography
JPS6226220A (ja) ケトプロフエン注射液
OSCAR FELSENFELD An alkaline tellurite lauryl sulfate-salt plate for the isolation of Vibrio comma
AU2009101067A4 (en) Storage stable compositions and methods for preparing same
JPH02200637A (ja) ドキソルビシン水溶液

Legal Events

Date Code Title Description
PC Assignment registered

Owner name: GUERBET LLC

Free format text: FORMER OWNER WAS: COOK IMAGING CORPORATION